BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Sports Medicine 2006;40:e7; doi:10.1136/bjsm.2005.019208
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lucia, A
Right arrow Articles by Arenas, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lucia, A
Right arrow Articles by Arenas, J

CASE REPORT

C34T mutation of the AMPD1 gene in an elite white runner

A Lucia1, M A Martin2, J Esteve-Lanao1, A F San Juan1, J C Rubio2, J Oliván1, J Arenas2

1 Universidad Europea de Madrid, Madrid, Spain
2 Hospital 12 de Octubre, Madrid

Correspondence to:
Correspondence to:
Professor Lucia
Department of Physiology, Universidad Europea de Madrid, Madrid 28670, Spain; alejandro.lucia{at}uem.es


ABSTRACT
The case is reported of an elite, male, white endurance runner (28 years of age), who is one of the best non-African runners in the world despite carrying the C34T mutation in the gene (AMPD1) that encodes the skeletal muscle specific isoform of AMP deaminase, an enzyme that plays an important role in muscle metabolism. The frequency of the mutant allele in sedentary white people is 8–11%. Previous research has shown that this mutation, at least in homozygotes, can impair the exercise capacity of untrained people and their trainability. The maximum oxygen uptake of the study subject was exceptionally high (83.6 ml/kg/min), whereas his ammonia and lactate concentrations at high submaximal running speeds were lower than those of other world class runners who are not carriers of the mutation. The partial metabolic deficiency of the study subject is possibly compensated for by his exceptionally favourable anthropometric characteristics (body mass index 18.2 kg/m2).


Abbreviations: AMPD, adenosine monophosphate deaminase; V·O2MAX, maximal oxygen uptake

Keywords: AMP deaminase; ammonia; endurance; genetics; maximum oxygen uptake




This article has been cited by other articles:


Home page
Br. J. Sports. Med.Home page
Online case reports
Br. J. Sports Med., March 1, 2006; 40(3): 213 - 213.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine